Cell Dissociation Market, By Product (Enzymatic Dissociation, Non-Enzymatic Dissociation, and Instruments & Accessories), By Dissociation (Tissue Dissociation and Cell Detachment), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America), The global Cell Dissociation Market size was estimated at USD 1.2 billion in 2023 and is projected to reach USD 1.9 billion in 2030 at a CAGR of 16.8% during the forecast period 2024-2030.
Top Companies Profile of Cell Dissociation Markets are: American Type Culture Collection, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, GE Healthcare, Pan-Biotech, Thermo Fisher Scientific, Merck KGaA, Danaher Corp, STEMCELL Technologies, Sartorius AG, Miltenyi Biotec, HiMedia Laboratories, S2 Genomics, Inc., Nuromics and More
Get Free Sample Report: https://www.delvens.com/get-free-sample/cell-dissociation-market
Cell Dissociation Market segmentation:
Based on Product
· Enzymatic Dissociation
· Non-Enzymatic Dissociation
· Instruments & Accessories
Based on the Dissociation
· Tissue Dissociation
· Cell Detachment
Based on the Tissue
· Connective Tissues
· Epithelial Tissues
· Other Tissues
Regional Analysis of Cell Dissociation Market:
North America dominate the cell dissociation market, commanding over 35.20% of total revenue. This leadership is underpinned by substantial government investments, a rising incidence of chronic diseases like cancer, and advanced clinical and laboratory research infrastructure. For instance, the United States reported approximately 2,188,458 new cancer cases and nearly 512,190 deaths in 2021, highlighting the region's healthcare challenges and focus on advancing cell-based therapies. These factors collectively enhance North America's position as a pivotal hub for biomedical research and therapeutic innovations, driving significant growth opportunities in the market.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/cell-dissociation-market
The cell dissociation market is integral to the biopharmaceutical industry's growth, particularly in the development of mammalian-based recombinant therapeutics. The shift towards mammalian cell culture has been substantial, with annual increases of 8.5% in approved recombinant products since 2003, reaching over 300 by mid-2021.
These products now constitute nearly 69% of therapeutics, underscoring their importance. Cell dissociation products, including traditional enzymatic solutions, have been crucial in cell isolation for research purposes despite potential cytotoxicity drawbacks. To address this, there's a growing trend towards non-enzymatic dissociation products that offer non-cytotoxic alternatives, enhancing cell viability and differentiation. This shift reflects increasing demand among researchers and biotechnology firms for safer and more effective dissociation methods.
Recent Developments
In March 2023, Agilent Technologies Inc. expanded its product offerings through the acquisition of e-MSion, a pioneering company known for the ExD cell, an innovative electron capture dissociation (ECD) technology.
In October 2022, Thermo Fisher Scientific introduced a closed and automated solution for cell isolation and bead removal, aiming to advance cell therapy manufacturing by enhancing cell purity, dissociation efficiency, and increasing recovery of target cells, thus enabling scalable production.
Access Full Report: https://www.delvens.com/report/cell-dissociation-market
In addition to the market data for the Cell Dissociation Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Frequently Asked Questions
What are the years considered to study Cell Dissociation Market intelligence report?
What is the compound annual growth rate (CAGR) of the Cell Dissociation Market?
Which region holds the largest market share in Cell Dissociation Market?
Which region is the fastest growing in Cell Dissociation Market?
Who are the major players in Cell Dissociation Market?
More Reports from Delvens:
Energy based Medical Aesthetics Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
